Articles by Disease (Fallopian Tube Cancer)

Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13
Page: 1398-1406
Author(s): Luca Vecchia, Carla Olivieri and Claudia Scotti

Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways

Journal: Current Cancer Drug Targets
Volume: 13
Page: 698-707
Author(s): Vijaya Galic, Robert L. Coleman and Thomas J. Herzog

Multifunctional Anti-Cancer Nano-Platforms are Moving to Clinical Trials

Journal: Current Drug Metabolism
Volume: 14
Page: 583-604
Author(s): Claudio Esposito, Annalisa Crema, Antonio Ponzetto, Giovanni Murtas and Guido Carloni

Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies

Journal: Current Molecular Medicine
Volume: 13
Page: 648-669
Author(s): F. Bellati, C. Napoletano, I. Ruscito, V. Visconti, M. Antonilli, M.L. Gasparri, I.G. Zizzari, H. Rahimi, I. Palaia, A. Rughetti, P. Benedetti Panici and M. Nuti

The PI3 Kinase Signaling Pathway in Prostate Cancer

Journal: Current Cancer Drug Targets
Volume: 13
Page: 157-164
Author(s): Aymen A. Elfiky and Zhenyang Jiang

Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers

Journal: Current Pharmaceutical Design
Volume: 19
Page: 864-882
Author(s): Libero Santarpia and Giulia Bottai

Incorporation of Anti-angiogenic Therapies in the Treatment of Epithelial Ovarian Cancer: Current Perspectives and Future Directions

Journal: Current Angiogenesis (Discontinued)
Volume: 1
Page: 266-276
Author(s): Ramez N. Eskander and Philip J. DiSaia